Original Research

Published on 01 Mar 2023

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway

in Pharmacology of Anti-Cancer Drugs

Jing Zhao
Yunfu Shi
Yubo Ma
Libin Pan
Yanan Wang
Li Yuan
Jinyun Dong
Jieer Ying

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1143427

2,260 views
2 citations

Original Research

Published on 28 Feb 2023

Comprehensive genomics analysis of aging related gene signature to predict the prognosis and drug resistance of colon adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Jubin Feng
Fengyihuan Fu
Yuqiang Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1121634

4,900 views
4 citations

Original Research

Published on 28 Feb 2023

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients

in Pharmacology of Anti-Cancer Drugs

Qinglin Li
Huangjie Zhang
Jinguo Hu
Lizhuo Zhang
Aiguang Zhao
He Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1124262

3,104 views
3 citations

Original Research

Published on 28 Feb 2023

Photo-functionalized TiO2 film for facile immobilization of EpCAM antibodies and efficient enrichment of circulating tumor cells

in Pharmacology of Anti-Cancer Drugs

Huan Deng
Xiangqin Liu
Jie Chen
Yi He
Lanke Lin
Xin Liu
Jiang Chen
Xiaoqi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1126602

1,455 views

Original Research

Published on 24 Feb 2023

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response

in Pharmacology of Anti-Cancer Drugs

Yun-Long Ma
Ya-Fei Yang
Han-Chao Wang
Chun-Cheng Yang
Lun-Jie Yan
Zi-Niu Ding
Bao-Wen Tian
Hui Liu
Jun-Shuai Xue
Cheng-Long Han

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1101749

5,076 views
6 citations

Editorial

Published on 24 Feb 2023

Editorial: Phytochemicals in cancer prevention and therapeutics: Current advancement and future perspective

in Pharmacology of Anti-Cancer Drugs

Subrata Kumar Pore
Suman Kumar Samanta
Bhaskarjyoti Gogoi
Eun-Ryeong Hahm

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1156197

1,526 views

Original Research

Published on 24 Feb 2023

A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth

in Pharmacology of Anti-Cancer Drugs

Uttara Saran
Balaji Chandrasekaran
Ashish Tyagi
Vaibhav Shukla
Amandeep Singh
Arun K. Sharma
Chendil Damodaran

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1150774

3,182 views
4 citations

Original Research

Published on 24 Feb 2023

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance

in Pharmacology of Anti-Cancer Drugs

Zhenzhen Chen
Zhihong Liu
Qian Zhang
Sheng Huang
Zaizhong Zhang
Xianquan Feng
Lingjun Zeng
Ding Lin
Lie Wang
Hongtao Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1133011

2,365 views
3 citations

Review

Published on 23 Feb 2023

Human PARP1 substrates and regulators of its catalytic activity: An updated overview

in Pharmacology of Anti-Cancer Drugs

Tao Zhu
Ju-Yan Zheng
Ling-Ling Huang
Yan-Hong Wang
Di-Fei Yao
Hai-Bin Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1137151

7,486 views
13 citations

Original Research

Published on 23 Feb 2023

The correlation between the costs and clinical benefits of PD-1/PD-L1 inhibitors in malignant tumors: An evaluation based on ASCO and ESMO frameworks

in Pharmacology of Anti-Cancer Drugs

Shen Lin
Yaping Huang
Liangliang Dong
Meiyue Li
Yahong Wang
Dian Gu
Wei Wu
Dongni Nian
Shaohong Luo
Xiaoting Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1114304

1,995 views
1 citation

Mini Review

Published on 23 Feb 2023

Aberrant splicing in human cancer: An RNA structural code point of view

in Pharmacology of Anti-Cancer Drugs

Maria Apostolidi
Vassiliki Stamatopoulou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1137154

4,488 views
4 citations

Case Report

Published on 23 Feb 2023

Case report: Idiopathic pulmonary fibrosis induced by nab-paclitaxel: A rare complication

in Pharmacology of Anti-Cancer Drugs

Jiahui Shen
Zhongyong Wen
Jingxia Lin
Huiwen Su

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1094844

3,020 views
1 citation

Original Research

Published on 22 Feb 2023

Identification of angiogenesis-related subtypes, the development of prognostic models, and the landscape of tumor microenvironment infiltration in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Chen Zhang
Tao Liu
Zhennan Yun
Bin Liang
Xue Li
Jiantao Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1103547

1,902 views
1 citation

Review

Published on 22 Feb 2023

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies

in Pharmacology of Anti-Cancer Drugs

Fan Yang
Qingjie He
Xiangpeng Dai
Xiaoling Zhang
Dong Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1143102

8,384 views
21 citations

Original Research

Published on 22 Feb 2023

Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes

in Pharmacology of Anti-Cancer Drugs

Liwen Liu
Qiuyue Hu
Yize Zhang
Xiangyi Sun
Ranran Sun
Zhigang Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1145408

2,370 views
5 citations

Original Research

Published on 22 Feb 2023

Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis

in Pharmacology of Anti-Cancer Drugs

Xing Liu
Xinhui Peng
Shuai Cen
Cuiting Yang
Zhijie Ma
Xinyuan Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1129662

4,280 views
24 citations

Navigation group

Articles

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway

Comprehensive genomics analysis of aging related gene signature to predict the prognosis and drug resistance of colon adenocarcinoma

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients

Photo-functionalized TiO2 film for facile immobilization of EpCAM antibodies and efficient enrichment of circulating tumor cells

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response

Editorial: Phytochemicals in cancer prevention and therapeutics: Current advancement and future perspective

A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance

Human PARP1 substrates and regulators of its catalytic activity: An updated overview

The correlation between the costs and clinical benefits of PD-1/PD-L1 inhibitors in malignant tumors: An evaluation based on ASCO and ESMO frameworks

Aberrant splicing in human cancer: An RNA structural code point of view

Case report: Idiopathic pulmonary fibrosis induced by nab-paclitaxel: A rare complication

Identification of angiogenesis-related subtypes, the development of prognostic models, and the landscape of tumor microenvironment infiltration in colorectal cancer

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies

Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes

Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis